OFFICIAL PUBLICATION OF

by its subsidiary APPco

Melanoma treatment to be PBS-listed

Megan Haggan 29/06/2015

melanoma: dermatologist examines mole on woman's shoulder

MSD has welcomed the Federal Government’s announcement that patients with the most deadly form of skin cancer – advanced melanoma – will be able to access the company’s anti-PD1 immunotherapy (pembrolizumab) on the PBS. Keytruda is a prescription-only medicine suitable for adult patients with unresectable or metastatic melanoma. News that Keytruda will be listed on

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

ACCC announces Chemist Warehouse/Sigma merger decision

I didn't realise there was a reply deadline here? Feel free to take your time and respond when you can…

John Smith

Counterfeit ivermectin

I disagree with you Leo, the TGA is our national regulator of medicines and medical devices and they do have…

Brad Sparling

Sigma/CWH merger to change pharmacy

Yeh their entire business model is to put Priceline in their shopping centres paying 3-4x the amount of rent a…

Bob Tran

Sigma/CWH merger to change pharmacy

The problem Wesfarmers have is that their control over individual Pricelines is too small compared to CWH. Any greater control…

Paul Sapardanis

Melanoma treatment to be PBS-listed

Previous Newly-identified enzyme key player in diabetes

Next MERS: thanks to international travel, Australia's not immune

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Newly-identified enzyme key player in diabetes

Next MERS: thanks to international travel, Australia's not immune

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.